COVID-19 and SARS-CoV-2. Modeling the present, looking at the future
E Estrada - Physics reports, 2020 - Elsevier
Abstract Since December 2019 the Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) has produced an outbreak of pulmonary disease which has soon become a …
(SARS-CoV-2) has produced an outbreak of pulmonary disease which has soon become a …
Immunoinformatics and vaccine development: an overview
AN Oli, WO Obialor, MO Ifeanyichukwu… - ImmunoTargets and …, 2020 - Taylor & Francis
The use of vaccines have resulted in a remarkable improvement in global health. It has
saved several lives, reduced treatment costs and raised the quality of animal and human …
saved several lives, reduced treatment costs and raised the quality of animal and human …
[HTML][HTML] The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
CM Arieta, YJ Xie, DA Rothenberg, H Diao, D Harjanto… - Cell, 2023 - cell.com
T cell responses play an important role in protection against beta-coronavirus infections,
including SARS-CoV-2, where they associate with decreased COVID-19 disease severity …
including SARS-CoV-2, where they associate with decreased COVID-19 disease severity …
pVACtools: a computational toolkit to identify and visualize cancer neoantigens
Identification of neoantigens is a critical step in predicting response to checkpoint blockade
therapy and design of personalized cancer vaccines. This is a cross-disciplinary challenge …
therapy and design of personalized cancer vaccines. This is a cross-disciplinary challenge …
Artificial intelligence in early drug discovery enabling precision medicine
Introduction: Precision medicine is the concept of treating diseases based on environmental
factors, lifestyles, and molecular profiles of patients. This approach has been found to …
factors, lifestyles, and molecular profiles of patients. This approach has been found to …
Induction of neoantigen-reactive T cells from healthy donors
M Ali, Z Foldvari, E Giannakopoulou, ML Böschen… - Nature protocols, 2019 - nature.com
The identification of immunogenic neoantigens and their cognate T cells represents the most
crucial and rate-limiting steps in the development of personalized cancer immunotherapies …
crucial and rate-limiting steps in the development of personalized cancer immunotherapies …
Structural vaccinology considerations for in silico designing of a multi-epitope vaccine
M Negahdaripour, N Nezafat, M Eslami… - Infection, Genetics and …, 2018 - Elsevier
Multi-epitope peptide vaccines, as a kind of fusion proteins, usually possess a string-of-
beads structure, consisting of several peptidic epitopes, probably adjuvants and linkers …
beads structure, consisting of several peptidic epitopes, probably adjuvants and linkers …
Nano-enabled COVID-19 vaccines: meeting the challenges of durable antibody plus cellular immunity and immune escape
AE Nel, JF Miller - ACS nano, 2021 - ACS Publications
At the time of preparing this Perspective, large-scale vaccination for COVID-19 is in
progress, aiming to bring the pandemic under control through vaccine-induced herd …
progress, aiming to bring the pandemic under control through vaccine-induced herd …
[HTML][HTML] APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy
CB Driscoll, MR Schuelke, T Kottke… - Nature …, 2020 - nature.com
APOBEC3B, an anti-viral cytidine deaminase which induces DNA mutations, has been
implicated as a mediator of cancer evolution and therapeutic resistance. Mutational plasticity …
implicated as a mediator of cancer evolution and therapeutic resistance. Mutational plasticity …
[HTML][HTML] Designing a multi-epitopic vaccine against the enterotoxigenic Bacteroides fragilis based on immunoinformatics approach
Enterotoxigenic Bacteroides fragilis is an enteric pathogen which is described as a
causative agent of various intestinal infections and inflammatory diseases. Moreover …
causative agent of various intestinal infections and inflammatory diseases. Moreover …